Clinical trial

Study for Patients Who Have Benefited and Tolerated Prior Panitumumab Treatment

NCT00425204

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2004-03-01

PhasePHASE2

Study timeline

Study start (unknown)2004-03-01Date precision: month

Registry last updated2008-09-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Colorectal Cancerunresolved

Non-Small Cell Lung Cancerunresolved

Prostate Cancerunresolved

Solid Tumorsunresolved

Advanced Renal Cell Carcinomaunresolved

Interventions

Panitumumab (ABX-EGF)DRUG

Sponsors & collaborators

Amgenlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00425204 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.